Bacillus Calmette???Gu??rin-induced granulomatous hepatitis in a patient with a superficial bladder carcinoma
Authors:
- Sven M FrancqueSFSven M Francque
- Paul A GentensPGPaul A Gentens
- Filip F De PauwFPFilip F De Pauw
- Erika Van Den BogaertEBErika Van Den Bogaert
- Eric A Van MarckEMEric A Van Marck
- Paul A PelckmansPPPaul A Pelckmans
- Peter P MichielsenPMPeter P Michielsen
- 1 October 2004
- journal article
- case report
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 16 (10) , 1027-1032
Abstract
A 71-year-old male patient with a superficial transitional cell carcinoma of the urinary bladder developed high fever and jaundice, accompanied by progressively increasing serum aminotransferase activities, 2 weeks after the fourth local instillation with an attenuated live strain of Mycobacterium bovis [bacillus Calmette-Guérin (BCG)]. A liver biopsy showed non-caseating granulomatous hepatitis. Cultures for mycobacteria were negative. Mycobacterial DNA was not detected in liver tissue using the polymerase chain reaction. Empirical treatment with rifampicin and isoniazid was started, resulting in partial recovery. After 6 months of therapy, however, serum aminotransferase activities were still twice the upper limit of normal. A second liver biopsy still demonstrated several granulomas. Only after addition of prednisolone, liver tests completely normalized. Also histologically the lesions improved dramatically. This suggests that the BCG hepatitis was at least partially caused by a hypersensitivity reaction. Our patient is the first reported case of BCG hepatitis with histological follow-up under therapy.Keywords
This publication has 19 references indexed in Scilit:
- Tuberculosis parotídea secundaria a instilación vesical con bcg: a propósito de un casoActa Otorrinolaringológica Española, 2003
- Intravesicale BCG-instillaties voor oppervlakkige blaastumoren. Een samenvatting voor de huisartsTijdschrift voor Geneeskunde, 2003
- Fatal Systemic Reaction after Multiple Doses of Intravesical Bacillus Calmette-Guérin for PolyposisAnnals of Pharmacotherapy, 2000
- The role of nitric oxide in bacillus Calmette-Guérin mediated anti-tumour effects in human bladder cancerBritish Journal of Cancer, 1998
- Incidence and Treatment of Complications of Bacillus Calmette-Guerin Intravesical Therapy in Superficial Bladder CancerJournal of Urology, 1992
- Long-term complete remission inbladder carcinoma in situ with intravesical tice bacillus Calmette guerinUrology, 1991
- Complications After Intravesical Instillation of Bacillus Calmette-guerin: Rhabdomyolysis and Metastatic InfectionJournal of Urology, 1991
- Use of Intravesical Bacillus Calmette-Guérin in the Treatment of Superficial Transitional Cell Carcinoma of the Bladder: An OverviewUrologia Internationalis, 1990
- Systemic Bacillus Calmette-Guérin Infection, ‘BCGitis’, in Patients Treated by Intravesical Bacillus Calmette-Guérin Therapy for Bladder CancerEuropean Urology, 1989
- Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder TumorsJournal of Urology, 1976